MLchartDataset catalogue

zelenoleucel

Term · Oncology and biomedicine · MLC-T-ONC-017659

A preparation of allogeneic multi-tumor-associated antigen (MultiTAA)-specific T lymphocytes, with potential immunomodulating and antineoplastic activities. Upon administration, zelenoleucel may target and kill tumor cells expressing the TAAs.

Table 1. Record
IdentifierMLC-T-ONC-017659
FieldOncology and biomedicine
Synonymsallogeneic MultiTAA-specific T lymphocytes MT-401; donor-derived multi-tumor-associated antigen-specific T cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-017659",
  "term": "zelenoleucel",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of allogeneic multi-tumor-associated antigen (MultiTAA)-specific T lymphocytes, with potential immunomodulating and antineoplastic activities. Upon administration, zelenoleucel may target and kill tumor cells expressing the TAAs.",
  "synonyms": [
    "allogeneic MultiTAA-specific T lymphocytes MT-401",
    "donor-derived multi-tumor-associated antigen-specific T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/zelenoleucel/"
}

Record 17,619 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.